RxDoctor Payments Data

Tim McGranahan, NP

Acute Care · Richmond, VANPI 1710061676

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Boston Scientific at 49.7% of the total. 2025 is the largest year on record at $2,477, more than ten times the $50 reported in 2021. Among acute care clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,520in general payments, 2019–2025

Across 55 payments — averaging $63.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Medtronic$2K
  • Impulse Dynamics (USA) Inc.$68
  • Johnson & Johnson$32
  • Abbott$16

What the payments were for

  • Travel & lodging$1,54244%
  • Food & beverage$1,96456%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,520 in reported general payments places this provider in the 90th percentile of 599 acute care providers in Virginia.

See all acute care providers in Virginia

Medicare billing

Part B allowed, 2024
$22,308
Medicare patients
164
Services billed
285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$41,202
Dofetilide79$15,172
Colchicine48$1,126
Amiodarone Hcl66$937
Sucralfate33$789
Naloxone Hcl13$778
Mupirocin108$711
Chlorhexidine Gluconate132$540
Metoprolol Succinate30$488
SotalolSotalol Hcl18$433
ClopidogrelClopidogrel Bisulfate47$402
Potassium Chloride16$274
Spironolactone11$48
Carvedilol14$32

Paid to pharmacies, not to this prescriber.

Other acute care in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →